Treatment of massive or life-threatening hemangiomas with recombinant α-interferon

Abstract
OBJECTIVE: To assess the response of massive, life-threatening, or function-impairing hemangiomas in pediatric patients receiving daily α2a-interferon subcutaneously.

This publication has 0 references indexed in Scilit: